Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Evaluation of buccal swabs for pharmacogenetics.

Ang JS, Aloise MN, Dawes D, Dempster MG, Fraser R, Paterson A, Stanley P, Suarez-Gonzalez A, Dawes M, Katzov-Eckert H.

BMC Res Notes. 2018 Jun 14;11(1):382. doi: 10.1186/s13104-018-3476-5.

2.

The A-Like Faker Assay for Measuring Yeast Chromosome III Stability.

Novoa CA, Ang JS, Stirling PC.

Methods Mol Biol. 2018;1672:1-9. doi: 10.1007/978-1-4939-7306-4_1.

PMID:
29043612
3.

Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study.

Dawes M, Aloise MN, Ang JS, Cullis P, Dawes D, Fraser R, Liknaitzky G, Paterson A, Stanley P, Suarez-Gonzalez A, Katzov-Eckert H.

CMAJ Open. 2016 Sep 21;4(3):E528-E534. eCollection 2016 Jul-Sep.

4.

Dosage Mutator Genes in Saccharomyces cerevisiae: A Novel Mutator Mode-of-Action of the Mph1 DNA Helicase.

Ang JS, Duffy S, Segovia R, Stirling PC, Hieter P.

Genetics. 2016 Nov;204(3):975-986. doi: 10.1534/genetics.116.192211. Epub 2016 Aug 31.

5.

Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer.

Duffy S, Fam HK, Wang YK, Styles EB, Kim JH, Ang JS, Singh T, Larionov V, Shah SP, Andrews B, Boerkoel CF, Hieter P.

Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):9967-76. doi: 10.1073/pnas.1611839113. Epub 2016 Aug 22.

6.

Inborn Error of Metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): An 8 year journey from pilot to current program.

Lim JS, Tan ES, John CM, Poh S, Yeo SJ, Ang JS, Adakalaisamy P, Rozalli RA, Hart C, Tan ET, Ranieri E, Rajadurai VS, Cleary MA, Goh DL.

Mol Genet Metab. 2014 Sep-Oct;113(1-2):53-61. doi: 10.1016/j.ymgme.2014.07.018. Epub 2014 Jul 23.

PMID:
25102806

Supplemental Content

Support Center